Merck administers dose to first patient in Phase III study of Oral Cladribine in Generalised Myasthenia Gravis (gMG) Read more
FDA approval of CAPVAXIVE will enhance protection against pneumococcal disease in older adults: GlobalData Read more
FDA approved KEYTRUDA in combination with chemotherapy for adult patients with endometrial carcinoma Read more
U.S. FDA approves CAPVAXIVE (V116), specifically designed for pneumococcal disease in adults Read more
Pharma industry focuses on strategic investments amid reduced deal activity by 26.1 % compared to May 2023: GlobalData Read more